PlainRecalls
FDA Devices Moderate Class II Ongoing

VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly

Reported: December 18, 2019 Initiated: November 16, 2018 #Z-0663-2020

Product Description

VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly

Reason for Recall

This recall is being initiated due to reports that that the therapy programming tablet with software version 1.5 errantly performs a normal mode diagnostic test instead of the selected system diagnostic test on Model 102 and Model 102R devices, if the output current is greater than 0.5mA. This can result in false high impedance values during patient follow-up.

Details

Recalling Firm
LivaNova USA Inc
Units Affected
643 units
Distribution
IL, AK, AL, AR, AZ, CA, CA , CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD MI, MN, MO, MS, MT, NC, ND, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WA , WI, WV, WY,
Location
Houston, TX

Frequently Asked Questions

What product was recalled?
VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly. Recalled by LivaNova USA Inc. Units affected: 643 units.
Why was this product recalled?
This recall is being initiated due to reports that that the therapy programming tablet with software version 1.5 errantly performs a normal mode diagnostic test instead of the selected system diagnostic test on Model 102 and Model 102R devices, if the output current is greater than 0.5mA. This can result in false high impedance values during patient follow-up.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 18, 2019. Severity: Moderate. Recall number: Z-0663-2020.